Vendome Acquisition Corp I (VNME) Form 10-Q Quarterly Reports
Vendome Acquisition Corp I (VNME) is a publicly traded company on the Nasdaq, categorized under SIC 6770 (Blank Checks). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VNME
CIK: 2055879
Exchange: Nasdaq
SIC 6770: Blank Checks
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Adeptus Partners LLC
Auditor SinceSince 2/28/2025 12:00:00 AM
Lead Engagement PartnerRicky McBride
Audit LocationOcean, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001905106-26-000149 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001140361-26-032487 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001604488-26-000076 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001905106-26-000108 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001140361-26-021287 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-14 | — | SCHEDULE 13G/A Filing | 0001076809-26-000057 | View SEC Doc Filr Page |
| 10-K | 2026-03-20 | 2025-12-31 | 10-K | 0001140361-26-010592 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-02-13 | — | SCHEDULE 13G Filing | 0001905106-26-000051 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-11 | — | SCHEDULE 13G/A Filing | 0000312069-26-000033 | View SEC Doc Filr Page |
| 10-Q | 2025-11-19 | 2025-09-30 | 10-Q | 0001140361-25-042736 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-11-14 | — | SCHEDULE 13G Filing | 0001604488-25-000238 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-11-14 | — | SCHEDULE 13G Filing | 0001905106-25-000081 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-11-14 | — | SCHEDULE 13G/A Filing | 0001140361-25-042315 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-11-14 | — | SCHEDULE 13G/A Filing | 0001193125-25-282895 | View SEC Doc Filr Page |
| NT 10-Q | 2025-11-14 | 2025-09-30 | NT 10-Q | 0001140361-25-042290 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-11-13 | — | SCHEDULE 13G Filing | 0001076809-25-000137 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-11-12 | — | SCHEDULE 13G Filing | 0000312069-25-000605 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-11-12 | — | SCHEDULE 13G Filing | 0001104659-25-109833 | View SEC Doc Filr Page |
| 8-K | 2025-08-21 | 2025-08-21 | 8-K | 0001140361-25-032231 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) | 0001140361-25-031288 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-03-31 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) | 0001140361-25-031260 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-08-14 | — | SCHEDULE 13G Filing | 0001140361-25-031208 | View SEC Doc Filr Page |
| 8-K | 2025-07-10 | 2025-07-03 | 8-K | 0001140361-25-025494 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-07-09 | — | SCHEDULE 13G Filing | 0000950170-25-094767 | View SEC Doc Filr Page |
| 8-K | 2025-07-03 | 2025-06-30 | 8-K | 0001140361-25-024847 | View SEC Doc Filr Page |